Search for: "In Re Brand Name Prescription Drugs Antitrust Litigation"
Results 1 - 20
of 22
Sorted by Relevance
|
Sort by Date
20 May 2008, 9:46 am
Plaintiffs’ expert plans to examine the impact of generic entry on brand name pharmaceuticals through an analysis of public data collected on the dispensation and purchases of prescription drugs. [read post]
9 Aug 2021, 2:02 am
If the dismissal stands, other name-brand drug makers may be encouraged to file dozens (or hundreds) of patents—regardless of their validity—when facing a patent cliff. [read post]
22 Nov 2022, 8:12 am
My name is Jeff Shinder and I’ll be your host. [read post]
1 Feb 2011, 4:01 am
Neurontin Antitrust Litig. v. [read post]
27 Feb 2015, 4:58 am
The decision of the First Circuit in In re Nexium Antitrust Litig., Nos. 14-1521, 14-1522, 2015 U.S. [read post]
31 Jul 2019, 10:30 am
It costs a lot to bring a branded drug to market. [read post]
28 May 2007, 11:26 pm
/Citibank, 264 F.3d 952, 958 (9th Cir.2001) (applying the "either viewpoint rule"); In re Brand Name Prescription Drugs Antitrust Litig., 123 F.3d 599, 609 (7th Cir.1997) (same); Oklahoma Retail Grocers Ass'n v. [read post]
11 Oct 2016, 5:13 am
The IPKat was rather less enthused by the decision.BackgroundServier are the suppliers of the original, branded version of Perindopril, which was supplied in the UK under the brand name "Coversyl". [read post]
26 May 2009, 8:50 am
For example, in In re Brand Name Prescription Drugs Antitrust Litigation, Brand, 1995 U.S. [read post]
23 Apr 2011, 4:49 am
Dinwoodie: suggests you’re still reluctant to impose prescriptive judgments about what should matter to consumers. [read post]
9 Mar 2020, 1:21 pm
Would help litigation, clarity. $3 million to litigate a patent, which is a big expense. [read post]
8 May 2012, 8:43 am
Prohibition on confusing brands and on promoting prescription drugs to the general public (many countries including EU). [read post]
26 May 2009, 8:50 am
For example, in In re Brand Name Prescription Drugs Antitrust Litigation, Brand, 1995 U.S. [read post]
5 Dec 2008, 1:00 pm
You can separately subscribe to the Pharma & Biotech Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360) (Patent Docs)… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in… [read post]
9 May 2008, 10:30 pm
: (Spicy IP), India: Merck vs Roche: towards differential pricing: (Spicy IP), India/Philippines: Access to drugs: The India/Philippines solution? [read post]
19 Sep 2008, 6:00 pm
: (rychlicki.net), United States: Is the Justice Department really thinking about going after all of Google’s business on antitrust? [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
4 Apr 2008, 1:00 am
: (creativecommons.org), Neil Netanel’s copyright paradox: (Patry Copyright Blog), Isn’t it ironic: TechCrunch blames the music industry for the dangerous ideas of Lessig and the free culture movement: (IPcentral.com) CFP: First interdisciplinary research workshop on free culture: (creativecommons.org), Of limitations, exceptions and verse (WIPO copyright committee): (KEI) Pharma & Biotech Pharma & Biotech - General StemCellPatents.com… [read post]
2 Feb 2010, 11:25 am
Any drug-legal or illegal, prescription or over-the-counter-can result in a positive test. [read post]
